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An overactive renin-angiotensin system is
associated with obesity and the metabolic syn-
drome. However, the mechanisms behind it are
unclear. Cleaving angiotensinogen to angioten-
sin I by renin is a rate-limiting stepof angiotensin
II production, but renin is suggested to have an-
giotensin-independent effects. We generated
mice lacking renin (Ren1c) using embryonic
stem cells from C57BL/6 mice, a strain prone
to diet-induced obesity. Ren1c/ mice are
lean, insulin sensitive, and resistant to diet-
induced obesity without changes in food intake
and physical activity. The lean phenotype is
likely due to a higher metabolic rate and gastro-
intestinal loss of dietary fat. Most of the meta-
bolic changes in Ren1c/ mice were reversed
by angiotensin II administration. These results
support a role for angiotensin II in the patho-
genesis of diet-induced obesity and insulin
resistance.
INTRODUCTION
The metabolic syndrome is characterized by central obe-
sity, hypertension, dyslipidemia, and impaired glucose tol-
erance. It increases the risk of coronary artery disease and
type 2 diabetes and is becoming increasingly prevalent
today (Farmer, 2004). Unifying theories of causality point
to primary defects in insulin action. Alternatively, an over-
active renin-angiotensin system (RAS) has also been
implicated in inducing the metabolic syndrome. Clinical
trials have demonstrated that pharmacological inhibition
of the RAS, using an angiotensin-converting enzyme
(ACE) inhibitor or a selective angiotensin II receptor
blocker (ARB), improves insulin sensitivity and decreases506 Cell Metabolism 6, 506–512, December 2007 ª2007 Elsevthe incidence of type 2 diabetes (Scheen, 2004). Mice
lacking angiotensinogen, the renin substrate, are lean
and resistant to diet-induced obesity, effects proposed
to reflect increased locomotor activity (Massiera et al.,
2001).
Renin catalyzes the rate-limiting step of angiotensin II
(Ang II) production, but it has the potential for Ang II-inde-
pendent effects (Nguyen, 2006). We have previously de-
scribed the generation of mice lacking renin (Ren1c) using
embryonic stem cells from C57BL/6 mice (Takahashi
et al., 2005). (C57BL/6 mice, like humans, have only one
renin gene, Ren1c [Sigmund and Gross, 1991] and are
prone to diet-induced obesity [Surwit et al., 1988].) As
expected, Ren1c/ mice have lower blood pressure,
and their plasma levels of renin, Ang I, and Ang II are un-
detectable (Takahashi et al., 2005). Here, we report that
mice lacking renin are lean, insulin sensitive, and resistant
to diet-induced obesity largely due to lack of Ang II, and
that Ang II-independent direct effects of renin on metabo-
lism are minimal.
RESULTS
Ren1c/ Mice Are Lean and Resistant to
Diet-Induced Obesity but Are Not Lipodystrophic
Compared to wild-type (WT) controls, Ren1c/ mice
weighed significantly less, and the difference increased
with age (Figure 1A). The difference in body weight be-
came more pronounced on a high-fat (HF) diet (Figure 1B;
see also Table S1 in the Supplemental Data available with
this article online). Theweight of the knockout mice did not
increase on the HF diet, despite the fact that the food in-
take of the knockout mice was not lower than that of WT
mice (Figures 1B and 1C; Table S1). The nose-to-rump
lengths of the mice indicate that the general linear body
growth of theRen1c/micewas not compromised (Table
S1). Their total and percentage body fat mass was none-
theless less than that of WT mice and did not increase
on the HF diet (Figure 1D). The Ren1c/ mice had lessier Inc.
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Resistant to Diet-Induced Obesity and
Store Less Triacylglycerol in Adipocytes
and Liver
(A) Growth curves of animals on regular chow
(RC). WT, wild-type.
(B and C) Changes in body weight (B) and food
intake (C) of male WT and Ren1c/ mice in-
duced by 2 months of RC or high-fat (HF) feed-
ing starting at 3 months of age.
(D and E) Body composition (D) and hematox-
ylin and eosin histology of adipose tissue and
liver (E) from mice fed a HF diet for 8 months
starting at 2 months of age. IWAT, inguinal
white adipose tissue; GWAT, gonadal white
adipose tissue; RWAT, retroperitoneal white
adipose tissue; BAT, interscapular brown adi-
pose tissue.
Data are from n R 6 animals per group.
*p < 0.0001 compared to WT. Error bars repre-
sent ± SEM.fat mass than WT controls in all adipose tissue depots
tested (Table S1), and they had smaller adipocytes than
WT mice (Figure 1E). Unlike lipodystrophic mice, the
Ren1c/ mice had decreased fat in the liver (Figure 1E;
Table S1). Thus, mice lacking renin are lean and resistant
to diet-induced obesity but are not lipodystrophic.
Increased Basal Metabolism in Mice
Lacking Renin
Possible mechanisms accounting for the leanness of the
Ren1c/ mice and their resistance to diet-induced obe-
sity include increased activity-related energy expenditure,
increased basal metabolism, and impaired nutrient
absorption. To test the differences in energy balance be-
tween the Ren1c/ and WT mice, we fed 3- to 5-month-
old mice a HF diet for 2 weeks and housed individual
mice in Oxymax cages for 5 days. The food consumption
and physical activity of the Ren1c/ and WT mice were
indistinguishable (Figures 2A and 2B). The total and resting
oxygen consumption and heat generation of theRen1c/
mice, normalized to lean body mass (LBM), were signifi-
cantly higher than those of WT mice (Figure 2C; Table
S2). Total heat generation of the Ren1c/ mice was 107Cell Metkcal/kg LBM/day higher than that ofWTmice,which corre-
sponds to 1.26 kcal/mouse/day. Consistent with in-
creased heat generation, expression of uncoupling pro-
teins (UCPs) in adipose tissues and in skeletal muscle of
Ren1c/ mice was significantly higher than that of WT
mice (Table S3). A >10% lower respiratory quotient (RQ)
in the Ren1c/ mice (Figure 2D) suggests that they have
increased fat combustion. This suggestion is further sup-
ported by increased plasma b-hydroxybutyrate (338.9 ±
29.5 mM in Ren1c/, 257.4 ± 18.0 mM in WT; p < 0.05)
and elevated mRNA expression of liver mitochondrial
HMG-CoA synthase 2 (215% ± 16% in Ren1c/, 100% ±
19% in WT; p < 0.01). Although the Ren1c/ mice had
higher heat generation than WT mice, the core body tem-
peratures of the Ren1c/ and WT mice were indistin-
guishable (38.3C ± 0.2C in Ren1c/, 38.4C ± 0.1C in
WT; n = 9 each, p = 0.42).We conclude that increased fatty
acid oxidation leads to increased basalmetabolism,which
contributes to the resistance to diet-induced obesity ob-
served in mice lacking renin, and that mice can maintain
core body temperature without renin.
Possible mechanisms accounting for the increased
basal metabolism include increased sympathetic nerveabolism 6, 506–512, December 2007 ª2007 Elsevier Inc. 507
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Renin and Adiposity/Insulin SensitivityFigure 2. Ren1c/ Mice Generate More
Heat, Excrete More Fat in Feces, and Ex-
press Less Pancreatic Lipase, Colipase,
and Adipose Tissue Dgat1
(A–F) Food intake (A), physical activity (B), heat
generation (C), respiratory quotient (RQ) (D),
fecal acid steatocrit (E), and dietary fat absorp-
tion (F) of 3- to 5-month-oldmales fed a HF diet
for 2 weeks.
(G–I) mRNA expression of pancreatic lipase
(G), pancreatic colipase (H), and Dgat1 (I) in
GWAT of 3-month-old RC-fed males.
Black bars, WT; white bars, Ren1c/. Data
are from n = 6–9 animals per group. *p < 0.05,
**p < 0.005 compared to WT. Error bars
represent ± SEM.activity, hyperthyroidism, and hyperadiponectinemia
(Bays, 2004). Ren1c/ mice have 30 mm Hg lower tail-
cuff blood pressure than WT mice (Takahashi et al.,
2005). This could stimulate the sympathetic nervous sys-
tem, but neither norepinephrine synthesis in adipose
tissue depots nor the plasma concentrations of epineph-
rine and norepinephrine differed between Ren1c/ and
WT animals (Table S4). Plasma thyroid hormone levels of
the Ren1c/ mice were not higher than those of WT
mice (Table S5). In contrast, plasma adiponectin levels
of 3- to 5-month-old Ren1c/ mice fed a HF diet for 4
weeks were almost three times higher than those of WT
mice (58.0 ± 1.9 mg/ml in Ren1c/, 21.0 ± 2.0 in WT;
n = 8 each, p < 0.0001). In addition, adiponectin has
been shown to increase the expression of UCPs (Masaki
et al., 2003), consistent with our observations. We con-
clude that hyperadiponectinemia of Ren1c/ mice likely
contributes to their increased fatty acid oxidation and
metabolic rate.
Dietary Fat Wasting in Mice Lacking Renin
Although the food intake of theRen1c/ andWTmice did
not differ (Figure 2A), the amount of lipid in the feces as es-
timated by acid steatocrit was more than twice as high in
Ren1c/mice (Figure 2E). The dietary fat absorption was
70 mg/mouse/day lower in Ren1c/ mice (Figure 2F),
which corresponds to a caloric deficit of 0.63 kcal/
mouse/day. Dietary lipids are predominantly triacylgly-
cerol, which forms micelles together with bile salts and
gets hydrolyzed by lipases before being absorbed in the
small intestine. Bile acid content in the liver and intestine508 Cell Metabolism 6, 506–512, December 2007 ª2007 Elseviewas indistinguishable between the two genotypes (Table
S6). In contrast, the expression levels of pancreatic lipase
and colipase in the Ren1c/ mice were both less than
20% of WT (Figures 2G and 2H). Because one pancreatic
lipase molecule requires one colipase molecule to be
active (Chaillan et al., 1989), <20% expression of both en-
zymes most likely leads to substantially less lipase activity
than in WT animals. In addition, because Ang II stimulates
pancreatic lipase secretion (Tsang et al., 2004), the
absence of Ang II in the Ren1c/ mice is expected to
decrease pancreatic lipase secretion. Further studies are
required to test whether the decrease in pancreatic lipase
and colipase that occurs in Ren1c/ mice is the primary
cause of steatorrhea.
Decreased Dgat1 Expression in Adipose Tissue
of Ren1c/ Mice
Ang II stimulates the proliferation and differentiation of
preadipocytes in vitro by increasing expression of adipo-
genic genes, including transcription factors (Crandall
et al., 1999; Kim et al., 2001; Saint-Marc et al., 2001). How-
ever, their expression in Ren1c/mice did not differ from
WT (Table S7). Nevertheless, because the adipocytes of
Ren1c/ mice are small, it is possible that their ability to
synthesize fat is impaired. In support of this possibility,
we found that the mRNA expression in Ren1c/ white
adipose tissue (WAT) of diacylglycerol acyltransferase 1
(Dgat1), the enzyme catalyzing the last step of triacylgly-
cerol synthesis, was about half of WT (Figure 2I). The
decreased Dgat1 expression was not compensated by
Dgat2 (Table S7). Because Dgat1 heterozygous knockoutr Inc.
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cause transplantation of WAT from Dgat1/ mice to WT
mice decreases adiposity (Chen et al., 2003), we conclude
that a decrease inDgat1 expression in adipose tissue con-
tributes significantly to the lean phenotype of Ren1c/
mice.
Ren1c/ Mice Are Insulin Sensitive
Consistent with previous findings that the decrease in
Dgat1 is associated with an increase in adiponectin and
that adiponectin improves insulin sensitivity (Chen et al.,
2002, 2003; Smith et al., 2000), the Ren1c/mice had in-
creased plasma adiponectin and decreased plasma fast-
ing glucose and insulin compared to WT mice, especially
on the HF diet (Table S8). They also required less insulin
to maintain similar levels of plasma glucose compared to
WTmice, as assessed by glucose tolerance test (Figure 3).
Because the animals for the glucose tolerance test were 4
months old and were maintained on normal chow, they
had similar fasting blood glucose levels and did not have
a large difference in body weight, suggesting that the
absence of renin (and Ang II) increases insulin sensitivity
rather than that WT mice develop insulin resistance sec-
ondary to obesity. Together, these observations lead to
the conclusion that increased plasma adiponectin in
Ren1c/ mice probably contributes to their improved
insulin sensitivity.
The Metabolic Phenotype of Ren1c/ Mice Is
Largely Explained by Lack of Ang II
To determine whether the metabolic phenotype of the
Ren1c/ mice is due to lack of Ang II caused by the ab-
sence of renin or to Ang II-independent direct effects of re-
nin, we infused Ren1c/ mice with a low dose of Ang II
(1.5 mg/day) andmaintained themon aHF diet for 4weeks.
Ang II increased body weight, body fat, and plasma insulin
and decreased steatocrit and plasma adiponectin of the
Ren1c/ mice to levels similar to WT without affecting
blood pressure, food intake, blood glucose, or plasma
creatinine (Figure 4). Ang II-treated Ren1c/ mice also
exhibited hydronephrosis similar to untreated knockouts
(data not shown).
Next, to test whether the low blood pressure of renin
knockout mice could explain the alteredmetabolic pheno-
type, we fedWTmice a HF diet with an angiotensin recep-
tor blocker, losartan; a calcium-channel blocker, amlodi-
pine; or a diuretic, furosemide, for 2 weeks to decrease
blood pressure to levels similar to Ren1c/ mice
(Figure S1A). The losartan group showed less of an in-
crease in body weight on the HF diet, less body fat gain,
lower plasma glucose, and higher plasma adiponectin
without a change in food intake or plasma insulin, indicat-
ing that losartan makes the animals resistant to diet-in-
duced obesity and insulin sensitive (Figure S1). The amlo-
dipine and furosemide groups exhibited food intake, body
fat, steatocrit, and insulin sensitivity similar to untreated
WT mice on a HF diet (Figure S1).
We conclude from these results that the absence of Ang
II is sufficient to explain the metabolic phenotype ofCell MetRen1c/ mice, that Ang II-independent direct effects of
renin are minimal, and that decreased blood pressure
and abnormal kidney function in Ren1c/ mice do not
contribute to their metabolic phenotype.
DISCUSSION
To establish the role of renin in the metabolic phenotype
in vivo, we have generatedmice lacking renin (Ren1c) using
embryonic stem cells from C57BL/6 mice, a strain prone
to diet-induced obesity. TheRen1c/mice are lean, insu-
lin sensitive, and resistant to diet-induced obesity without
changes in food intake and physical activity. They lose di-
etary fat in the feces, likely due to decreased expression of
pancreatic lipase and colipase. They also have a highmet-
abolic rate and increased fatty acid oxidation, which are
associated with decreased expression of Dgat1, and in-
creased adiponectin. Because the adiposity, insulin sensi-
tivity, and Dgat1 expression levels in the Ren1c/ mice
are similar to those of heterozygous Dgat1+/ mice
(Chen et al., 2003), the decreased Dgat1 expression likely
explains the metabolic phenotype of the Ren1c/ mice.
Increased adiponectin is likely at least partly responsible
for the high energy expenditure and improved insulin sen-
sitivity of the Ren1c/mice; however, other factors could
also be involved.
Renin catalyzes the rate-limiting step of Ang II produc-
tion, but it has the potential for Ang II-independent effects
(Nguyen, 2006). Mice lacking angiotensinogen (Agt), the
renin substrate, are also lean and resistant to diet-induced
obesity (Massiera et al., 2001). However, unlike Ren1c/
mice, Agt/ mice are more physically active and have
a metabolic rate similar to WT, and they do not show
dietary lipid wasting (Massiera et al., 2001). Because
Agt/ mice have very high levels of renin (Tanimoto
et al., 1994), Ang II-independent direct effects of renin
could be responsible for the difference in phenotype
between mice lacking renin and mice lacking angiotensi-
nogen. However, Ang II reverses the metabolic phenotype
of Ren1c/ mice without affecting blood pressure,
plasma creatinine, or hydronephrosis. In addition, losar-
tan-treated WT mice fed a high-fat diet show a phenotype
Figure 3. Ren1c/ Mice Have Improved Insulin Sensitivity
Plasma glucose (A) and insulin (B) levels during glucose tolerance test.
Mice were 4-month-old RC-fed males. Data are from n = 6 animals per
group. *p<0.05, **p<0.001comparedtoWT.Errorbars represent±SEM.abolism 6, 506–512, December 2007 ª2007 Elsevier Inc. 509
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Renin and Adiposity/Insulin SensitivityFigure 4. A Low Dose of Ang II Abrogates the Metabolic Phenotype of Ren1c/ Mice
Blood pressure (A), food intake (B), body weight (C), body fat (% body weight) (D), fecal acid steatocrit (E), plasma glucose (F), plasma insulin (G),
plasma adiponectin (H), and plasma creatinine (I) of Ren1c/ mice implanted with placebo pellets, Ren1c/ mice implanted with pellets releasing
Ang II (1.5 mg/day), andWT control mice implanted with placebo pellets. All mice weremaintained on a HF diet starting at pellet implantation, and data
were obtained after 4 weeks of treatment. nR 5. Error bars represent ± SEM.qualitatively similar to that ofRen1c/mice, whereas am-
lodipine and furosemide, which decreased blood pressure
of WTmice to levels similar to Ren1c/mice, did not rep-
licate the metabolic phenotype of the knockout mice.
These results indicate that lack of Ang II is sufficient to ex-
plain the metabolic phenotype of mice lacking renin and
that Ang II-independent direct metabolic effects of renin
are minimal. Moreover, the kidney developmental defect
and low blood pressure per se do not affect the metabolic
phenotype of Ren1c/ mice.
Becausemuch of the metabolic phenotype of Ren1c/
mice is replicated by losartan, it is expected that the
metabolic phenotype of Ren1c/ mice should be similar
to that of mice lacking the type 1a Ang II receptor (Agtr1a/).
Indeed Agtr1a/ mice are also lean, resistant to diet-510 Cell Metabolism 6, 506–512, December 2007 ª2007 Elsevinduced obesity, and exhibit a high metabolic rate
(Kouyama et al., 2005). Interestingly, heterozygous
Agtr1a+/ mice are also resistant to diet-induce obesity,
whereas heterozygous Ren1c+/ mice are indistinguish-
able from WT in every parameter measured (data not
shown). This is probably because the plasma and kidney
renin levels of heterozygous Ren1c+/ mice are indistin-
guishable from those of WT due to the tight feedback
regulation of renin (Takahashi et al., 2005), whereas
Agtr1a+/mice express 50% of the WT level of the Agtr1a
gene product (Ito et al., 1995). However, this does not ex-
clude the possibility, currently under investigation using
our renin-overexpressing mice, that a mild increase in
the expression of renin, which we expect in the human
population, could cause obesity and insulin resistance.ier Inc.
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mice could be because the Soxhlet petroleum benzene
extraction method that Massiera et al. (2001) used was
not as sensitive in quantifying fecal lipid as our acid stea-
tocrit method and was not able to detect the increase in
fecal fat of the Agt/ mice. Another possibility is the
difference in genetic backgrounds. Our Ren1c/ mice
were generated using C57BL/6 embryonic stem cells
and were maintained on the same strain (i.e., were coiso-
genic), whereas the Agt/ mice were generated using
embryonic stem cells from F1 mice obtained by mating
C57BL/6 and CBA mice and were backcrossed to the
ICR strain (Tanimoto et al., 1994). The difference in the ge-
netic background possibly introduces differences in gene
expression that modify and obscure the phenotype. The
difference in the genetic background also likely explains
why the Agt/ mice exhibit increased physical activity
and a similar metabolic rate compared to WT mice.
Our study demonstrates that mice lacking renin are
lean, resistant to diet-induced obesity, and more insulin
sensitive than WT mice. This metabolically favorable state
results partly from an increased metabolic rate and partly
from gastrointestinal loss of dietary fat, but not from in-
creased physical activity or decreased food intake. Lack
of Ang II is sufficient to explain the metabolic phenotype
of mice lacking renin, and Ang II-independent direct
effects of renin on metabolism are minimal. Our findings
are particularly relevant since they suggest that renin
inhibitors recently approved or under development for
the treatment of hypertension are likely to have favorable
effects on obesity, insulin sensitivity, and their associated
metabolic and cardiovascular consequences.
EXPERIMENTAL PROCEDURES
Mice
The generation of Ren1c/ mice has been described previously
(Takahashi et al., 2005). Mice were housed in standard cages on
a 12:12 hr light/dark cycle, allowed free access to regular chow (RC)
and water, and handled in accordance with NIH guidelines for the
care and use of experimental animals, as approved by the Institutional
Animal Care and Use Committee of UNC-Chapel Hill. In some experi-
ments, a high-fat (HF) diet (TD.88137, Harlan Teklad) was used. Fat
content of the RC diet was 17% of calories, and that of the HF diet
was 42% of calories.
Dual-Energy X-Ray Absorptiometry
A Lunar PIXImus dual-energy X-ray absorptiometry (DEXA) scanner
was used to estimate the amount of body fat and lean body mass
(Brommage, 2003; Nagy and Clair, 2000).
Magnetic Resonance Imaging
In some experiments, body composition of mice was evaluated using
an EchoMRI-100 (Echo Medical Systems) according to the manufac-
turer’s instructions.
Metabolic Studies
Mice were placed individually in chambers of an Oxymax system
(Columbus Instruments) for 96 hr, and readings were taken 24 hr after
acclimation. Measures of food and water intake, O2 consumption, CO2
production, respiratory quotient, and physical activity were obtained.
Data were collected and analyzed via Oxymax Windows software ver-Cell Mesion 2.3. Measurement and settle times were set at 60 and 120 s,
respectively.
Acid Steatocrit
Acid steatocrit was measured as described previously (Tran et al.,
1994) with minor modification. In short, 0.05 g of powdered specimen
was mixed in 200 ml of 1 N perchloric acid. One drop of 0.5% oil red O
was added and mixed. Specimens were placed in nonheparinized
capillary tubes and spun. Steatocrit was calculated as 100 3 length
of fatty layer/(length of solid layer + length of fatty layer).
b-Hydroxybutyrate, Insulin, Leptin, Adiponectin, T3, T4,
and Glucose Tolerance Test
Mice were fasted 4 hr before blood was drawn. Plasma b-hydroxybu-
tyrate was determined using a reagent kit (Wako or Sigma-Aldrich).
Plasma levels of insulin, leptin, and adiponectin were determined using
ELISA kits (Crystal Chem Inc. for insulin and leptin; B-Bridge Interna-
tional Inc. for adiponectin). T3 and T4 were determined using Coat-
A-Count (Diagnostic Products Corporation). Glucose tolerance test
was carried out as described previously (Tsai et al., 2004).
Bile Acids
Bile acids were extracted from livers and intestines as described pre-
viously (Dawson et al., 2003; Locket andGallaher, 1989) andmeasured
using a total bile acids kit (Wako).
Catecholamines
Norepinephrine and epinephrine in plasma, hearts, and adipose
tissues were measured using HPLC as described previously (Bowers
et al., 2004). Norepinephrine turnover, a measure of its synthesis in ad-
ipose tissue and heart, was calculated as described previously (Brodie
et al., 1966).
Ang II, Losartan, Amlodipine, and Furosemide Experiments
In Vivo
Pellets releasing 1.5 mg/day Ang II or placebo pellets (Innovative
Research of America) were subcutaneously implanted in 6-week-old
male Ren1c/mice, and the animals were maintained on HF diet. Af-
ter 4 weeks, blood pressure; body composition; food intake; steatocrit;
and plasma glucose, insulin, adiponectin, and creatinine were mea-
sured. In another set of experiments, 3-month-old male C57BL/6 WT
mice were fed HF diet with or without 0.45 g/l losartan (Merck & Co.,
Inc.) in drinking water containing 5% sucrose, 60 mg amlodipine/kg
food, or 0.1 g furosemide/l drinking water. After 2 weeks, blood pres-
sure; body composition; food intake; steatocrit; and plasma glucose,
insulin, and adiponectin were measured.
Quantitative RT-PCR
mRNA expression was quantified using an ABI Prism 7700 Sequence
Detection System (Applied Biosystems) as described previously
(Takahashi et al., 2005). Primers and probes are listed in Table S9.
Statistical Analyses
All values are expressed as mean ± SEM. Data were analyzed by Stu-
dent’s t test or analysis of variance (ANOVA). A multiple-comparison
Tukey-Kramer post hoc test was performed with JMP software version
6 (SAS Institute, Inc.) to evaluate differences between groups.
Supplemental Data
Supplemental Data include nine tables and one figure and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/6/6/506/DC1/.
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